Johnson & Johnson (JNJ) Common Equity (2016 - 2025)
Historic Common Equity for Johnson & Johnson (JNJ) over the last 17 years, with Q4 2025 value amounting to $81.5 billion.
- Johnson & Johnson's Common Equity rose 1406.35% to $81.5 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $81.5 billion, marking a year-over-year increase of 1406.35%. This contributed to the annual value of $81.5 billion for FY2025, which is 1406.35% up from last year.
- As of Q4 2025, Johnson & Johnson's Common Equity stood at $81.5 billion, which was up 1406.35% from $79.3 billion recorded in Q3 2025.
- In the past 5 years, Johnson & Johnson's Common Equity registered a high of $81.5 billion during Q4 2025, and its lowest value of $63.3 billion during Q1 2021.
- Moreover, its 5-year median value for Common Equity was $71.5 billion (2024), whereas its average is $73.0 billion.
- As far as peak fluctuations go, Johnson & Johnson's Common Equity skyrocketed by 1698.06% in 2022, and later crashed by 1045.52% in 2023.
- Over the past 5 years, Johnson & Johnson's Common Equity (Quarter) stood at $70.3 billion in 2021, then grew by 6.16% to $74.6 billion in 2022, then fell by 7.81% to $68.8 billion in 2023, then increased by 3.95% to $71.5 billion in 2024, then rose by 14.06% to $81.5 billion in 2025.
- Its last three reported values are $81.5 billion in Q4 2025, $79.3 billion for Q3 2025, and $78.5 billion during Q2 2025.